Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

676 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide.
Oka T, Hatano K, Tani M, Yoshimura A, Horibe Y, Liu Y, Sassi N, Okuda Y, Yamamoto A, Uemura T, Yamamichi G, Ishizuya YU, Yamamoto Y, Kato T, Kawashima A, Fujita K, Nonomura N. Oka T, et al. Among authors: nonomura n. Cancer Diagn Progn. 2024 Nov 3;4(6):706-714. doi: 10.21873/cdp.10385. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502601 Free PMC article.
Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.
Yamamoto A, Kawashima A, Sakai S, Mita M, Sassi N, Inoguchi S, Horibe Y, Yoshimura A, Tani M, Yutong L, Okuda Y, Oka T, Uemura T, Yamamichi G, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Hatano K, Kakuta Y, Imamura R, Takahara S, Kimura T, Nonomura N. Yamamoto A, et al. Among authors: nonomura n. Biochem Biophys Res Commun. 2024 Nov 12;733:150701. doi: 10.1016/j.bbrc.2024.150701. Epub 2024 Sep 14. Biochem Biophys Res Commun. 2024. PMID: 39326256 Free article.
Performance of the New CKD-EPI Creatinine-and Cystatin C-based Glomerular Filtration Rate Estimation Equation in Living Kidney Donor Candidate.
Kakuta Y, Maegawa-Higa Y, Matsumura S, Fukae S, Tanaka R, Yonishi H, Nakazawa S, Yamanaka K, Isaka Y, Nonomura N. Kakuta Y, et al. Among authors: nonomura n. Transplant Direct. 2024 Sep 19;10(10):e1712. doi: 10.1097/TXD.0000000000001712. eCollection 2024 Oct. Transplant Direct. 2024. PMID: 39310284 Free PMC article.
Prediction of undetectable circulating tumor DNA by comprehensive genomic profiling assay in metastatic prostate cancer: the SCRUM-Japan MONSTAR SCREEN project.
Shiota M, Matsubara N, Kato T, Eto M, Osawa T, Abe T, Shinohara N, Nishimoto K, Yasumizu Y, Tanaka N, Oya M, Fujisawa T, Horasawa S, Nakamura Y, Yoshino T, Nonomura N. Shiota M, et al. Among authors: nonomura n. World J Urol. 2024 Sep 18;42(1):526. doi: 10.1007/s00345-024-05240-6. World J Urol. 2024. PMID: 39292288
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.
Yoshimura A, Kato T, Nakai Y, Tsujihata M, Toyoda S, Sato M, Matsuzaki K, Nakata W, Takao T, Inoguchi S, Okuda Y, Yamamichi G, Ishizuya Y, Yamamoto Y, Hatano K, Kawashima A, Takada S, Inoue H, Nishimura K, Miyake O, Fujita K, Nakayama M, Nishimura K, Nonomura N. Yoshimura A, et al. Among authors: nonomura n. Int J Clin Oncol. 2024 Sep 2. doi: 10.1007/s10147-024-02612-1. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39222148
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer.
Iida N, Imai M, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Ebi H, Taniguchi H, Nonomura N, Sunakawa Y, Shiozawa M, Yamazaki K, Boku S, Bando H, Shiraishi Y, Kobayashi M, Goto H, Sato A, Fujii S, Yoshino T, Nakamura Y. Iida N, et al. Among authors: nonomura n. Clin Cancer Res. 2024 Sep 13;30(18):4167-4178. doi: 10.1158/1078-0432.CCR-24-1023. Clin Cancer Res. 2024. PMID: 39163021 Free PMC article.
676 results